Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Lerman

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
The Journal of Rheumatology|January 17, 2019
Standardizing Terminology and Assessment for Orofacial Conditions in Juvenile Idiopathic Arthritis: International, Multidisciplinary Consensus-based RecommendationsPeter Stoustrup, Cory M Resnick, Thomas Klit Pedersen, et al.
Lancet (London, England)|November 12, 2021
Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trialNicolino Ruperto, Hermine I Brunner, Olga Synoverska, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
The Journal of Rheumatology|January 17, 2019
Standardizing Terminology and Assessment for Orofacial Conditions in Juvenile Idiopathic Arthritis: International, Multidisciplinary Consensus-based RecommendationsPeter Stoustrup, Cory M Resnick, Thomas Klit Pedersen, et al.
Lancet (London, England)|November 12, 2021
Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trialNicolino Ruperto, Hermine I Brunner, Olga Synoverska, et al.
Pageof 1